Gain Therapeutics, Inc.

GANX - CIK 0001819411

Market cap-

Rank-

SEC filings224

GANX income statement (quarterly)

The table below shows Gain Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Line item	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024
Revenue	-	-	-	-	-	-
Cost of revenue	-	-	-	-	-	-
Gross profit	-	-	-	-	-	-
R&D	$2.76M	$2.85M	$2.76M	$2.26M	$2.62M	$4.44M
SG&A

GANX annual revenue (10-K history)

Gain Therapeutics, Inc. reported annual revenue of $55.18K for fiscal year 2023. That is down 60.6% from $140.11K in fiscal 2022. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.